Lidocaine and Ketamine Infusions as Adjunctive Pain Management Therapy: A Retrospective Analysis of Clinical Outcomes in Hospitalized Patients Admitted for Pain Related to Sickle Cell Disease
ObjectiveIn this study, we aim to evaluate the efficacy of adjunctive lidocaine and ketamine infusions for opioid reduction in the treatment of sickle cell disease in patients with vaso-occlusive crisis (VOC).DesignWe retrospectively reviewed a cohort of 330 adult sickle-cell crisis hospital encount...
Main Authors: | Nicolas A. Zavala, Randall W. Knoebel, Magdalena Anitescu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Pain Research |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpain.2022.878985/full |
Similar Items
-
Lidocaine infusion for the treatment of burn pain: A review of recent updates
by: Attia Attia, et al.
Published: (2022-10-01) -
Comparative analysis of opioid use in sickle cell crisis in an urban facility in Ghana
by: Marian Opoku‐Agyakwa, et al.
Published: (2023-08-01) -
Vaso-Occlusive Pain and Menstruation in Sickle Cell Disease: A Focus Group Analysis
by: Melissa Day, et al.
Published: (2020-01-01) -
Considerations for Cannabis Use to Treat Pain in Sickle Cell Disease
by: Donovan A. Argueta, et al.
Published: (2020-12-01) -
Short- and long-term follow-up and additional benefits in a sickle cell disease patient experienced severe crizanlizumab infusion-related vaso-occlusive crisis: A case report
by: Awni Alshurafa, et al.
Published: (2022-11-01)